Skip to content
Sunday, October 11, 2026

The business briefing leaders read first.

Subscribe

Health

Trump Administration Finalizes Health Price Transparency Rules, Pressures Hospitals to Post Real Prices

New federal rules finalized October 5 require hospitals and insurers to publish actual dollar prices — and ban the "ghost rates" regulators say obscured real costs.

Share WhatsApp Facebook X LinkedIn Email
The Massachusetts General Hospital campus in Boston
Public domain, via Wikimedia Commons

The Trump administration finalized sweeping healthcare price transparency rules on October 5, 2026, requiring hospitals and insurers to publish actual dollar amounts for services — and banning the hidden “ghost rates” regulators say rendered earlier disclosures useless.

The regulations, finalized by the Centers for Medicare & Medicaid Services in coordination with the Departments of Labor and the Treasury, build on price transparency rules first established during Trump’s first term. Hospitals must now publish actual dollar amounts at the 10th, 90th and median percentile for each service, making prices far more usable than the dense machine-readable files of the past. Insurers must strip out meaningless data, provide real in-network dollar figures, expand out-of-network disclosures and offer personalized cost estimates by phone and online.

Both hospitals and insurers must name senior officials who attest that pricing data is complete and accurate. Enforcement began the same day: Federal Trade Commission Chairman Andrew Ferguson sent warning letters to 24 of the nation’s largest health systems over incomplete price disclosures. “I’m guaranteeing you we will find you. And when we find you, we will fine you,” CMS Administrator Dr. Mehmet Oz said at the launch event.

“Americans should know what their healthcare will cost before they receive it,” said HHS Secretary Robert F. Kennedy Jr., adding that the rules give patients clearer information to compare costs and understand coverage. Oz argued that greater transparency drives competition, reduces price disparities and helps lower costs.

The push comes as polling shows healthcare costs are voters’ top affordability worry this midterm season. Regulators also said they will begin developing the system for disclosing prescription drug prices next month, with a final plan expected by next May and enforcement by the end of 2027 — a step officials punted on last year after heavy industry resistance.

Hospital groups have long argued that machine-readable files satisfy the spirit of transparency; regulators are now betting that readable dollar figures will do what file dumps did not.

Recent articles by CEO Health & Science Desk

More from Health